June 21, 2016

New Link Found Between Diabetes, Alzheimer’s Disease

LONDON -- June 21, 2016 --Alzheimer’s disease and type 2 diabetes are so closely related that drugs currently used to control glucose levels in diabetes may also alleviate the symptoms and progression of Alzheimer’s disease, according to a study published in the journal Diabetologia.

Researchers found for the first time that dementia-related complications within the brain can also lead to changes in glucose handling and ultimately diabetes. This is contrary to what was previously thought -- that diabetes begins with a malfunction in the pancreas or a high-fat, high-sugar diet.

Bettina Platt, MD, University of Aberdeen, Aberdeen, United Kingdom, and colleagues developed a model of Alzheimer’s disease and were surprised to find that increased levels of a gene involved in the production of toxic proteins in the brain not only led to Alzheimer’s-like symptoms, but also to the development of diabetic complications.

“Many people are unaware of the relationship between diabetes and Alzheimer’s disease, but the fact is that around 80% of people with Alzheimer’s disease also have some form of diabetes or disturbed glucose metabolism,” said Dr. Platt. “This is hugely relevant as Alzheimer’s is in the vast majority of cases not inherited, and lifestyle factors and comorbidities must therefore be to blame.”

“Our research teams are particularly interested in the impact of lifestyle related factors in dementia and by collaborating with experts in diabetes and metabolism, we have been able to investigate the nature of the link in great detail,” she added. “Until now, we always assumed that obese people get type 2 diabetes and then are more likely to get dementia. We now show that actually it also works the other way around.

“Additionally, it was previously believed that diabetes starts in the periphery, but here we show that dysregulation in the brain can equally lead to development of very severe diabetes, so again showing that diabetes doesn’t necessarily have to start with your body getting fat, it can start with changes in the brain,” said Dr. Platt.

“This study provides a new therapeutic angle into Alzheimer’s disease and we now think that some of the compounds that are used for obesity and diabetic deregulation might potentially be beneficial for Alzheimer’s patients as well,” she concluded. “The good news is that there are a number of new drugs available right now which we are testing to see if they would reverse both Alzheimer’s and diabetes symptoms. We will also be able to study whether new treatments developed for Alzheimer’s can improve both, the diabetic and cognitive symptoms.”

SOURCE: Tony Kirby PR
Log in or register to post comments

DG News saves you time by delivering a short list of medical developments worthy of your time and attention. Our advanced algorithms rank clinical content based on hundreds of data points to surface the most important medical advances impacting your practice each week.